While semaglutide is one of the most well-known treatment options, it isnt the only medication available
The Wegovy Injection: In the landmark STEP 1 clinical trial , patients using the 2.4 mg weekly injection lost an average of 14.9% of their body weight over 68 weeks, vs 2.4% with the placebo group
Related Stories GLP-1 weight loss may reduce first-impression penalties in relationships and hiring Weight loss drugs may reduce binge eating disorder symptoms Semaglutide dose may matter more than weight loss for heart health Data collected was weight using calibrated scales, laboratory results for fasting blood glucose [FBG], lipid panel, glycosylated hemoglobin [HbA1c], blood pressure [BP] readings, and liver function tests [LFTs]
Biol Neonate 25 , 95107
This allows residents to enjoy the foods they love while still experiencing steady progress
Over time, and depending on the patients response to treatment, the dose can be increased in increments of 2.5 mg weekly to a maximum of 15 mg once a week